| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 300,250 | 244,206 | 254,372 | 284,986 | | Cost of Revenue | 138,421 | 114,027 | 115,947 | 135,550 | | | Gross Profit | 161,829 | 130,179 | 138,425 | 149,436 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 69,046 | 64,402 | 177,643 | 67,644 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 92,783 | 65,777 | (39,218) | 81,792 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 402 | (2,523) | 1,380 | 2,111 | | Earnings Before Interest And Taxes | 93,185 | 63,254 | (37,838) | 83,903 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 93,185 | 63,254 | (37,838) | 83,903 | | Income Tax Expense | 35,895 | 21,689 | (14,390) | 31,466 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 57,290 | 41,565 | (23,448) | 52,437 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 57,290 | 41,565 | (23,448) | 52,437 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $57,290 | $41,565 | ($23,448) | $52,437 |
|
0.26% Nasdaq 
Income Statement
